[Allergo-immunology. Clinical immunology].
Copyright policy )[Allergo-immunology. Clinical immunology].
The past year has been characterized by significant novelties from the point of view of the clinical immunologist. With the BLISS 52 study showing that belimumab has the ability to decrease the activity of systemic lupus erythematosus (SLE) resistant to conventional therapy an important step towards the control of this difficult disease has been carried forward. In addition, the long-term results of the ALMS study have demonstrated that mycophenolate mofetil is superior to azathioprine in maintaining the remission in patients with severe lupus nephritis. Furthermore, the results of the RAVE and RITUXVASC studies have documented that rituximab is a valid alternative to cyclophosphamide in the control of ANCA associated vasculitis.
Evidence-Based Medicine, Remission Induction, Antibodies, Monoclonal, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Mycophenolic Acid, Antibodies, Monoclonal, Humanized, Lupus Nephritis, Severity of Illness Index, Antibodies, Monoclonal, Murine-Derived, Treatment Outcome, Cardiovascular Diseases, Antirheumatic Agents, Azathioprine, Humans, Lupus Erythematosus, Systemic, Drug Therapy, Combination, Rituximab, Immunosuppressive Agents, Randomized Controlled Trials as Topic
Evidence-Based Medicine, Remission Induction, Antibodies, Monoclonal, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Mycophenolic Acid, Antibodies, Monoclonal, Humanized, Lupus Nephritis, Severity of Illness Index, Antibodies, Monoclonal, Murine-Derived, Treatment Outcome, Cardiovascular Diseases, Antirheumatic Agents, Azathioprine, Humans, Lupus Erythematosus, Systemic, Drug Therapy, Combination, Rituximab, Immunosuppressive Agents, Randomized Controlled Trials as Topic
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!